/

Faeth Therapeutics

Developing metabolic cancer therapies and kinase inhibitor treatments.

BiotechnologyOncology faeththerapeutics.com ↗

Company facts

Founded: 2019
Employees: 50
Headquarters: United States
Type: Public
Listed: NASDAQ: SNSE